Literature DB >> 15115754

FGF signaling functions in the hypodermis to regulate fluid balance in C. elegans.

Peng Huang1, Michael J Stern.   

Abstract

Signaling by the Caenorhabditis elegans fibroblast growth factor receptor EGL-15 is activated by LET-756, a fibroblast growth factor, and attenuated by CLR-1, a receptor tyrosine phosphatase. Hyperactive EGL-15 signaling results in a dramatic Clr phenotype characterized by the accumulation of clear fluid within the pseudocoelomic space, suggesting that regulated EGL-15 signaling is essential for fluid homeostasis in C. elegans. To determine the cellular focus of EGL-15 signaling, we identified an enhancer element (e15) within the egl-15 promoter, which is both necessary for the promoter activity and sufficient when duplicated to drive either egl-15 or clr-1 rescue activity. This enhancer drives GFP expression in hypodermal cells. Consistent with this finding, immunofluorescence studies of EGL-15 indicate that EGL-15 is expressed in hypodermal cells, and hypodermal promoters can drive full clr-1 and egl-15 rescue activity. Moreover, a mosaic analysis of mpk-1, which acts downstream of egl-15, suggests that its suppression of Clr (Soc) function is required in the hypodermis. These results suggest that EGL-15 and CLR-1 act in the hypodermis to regulate fluid homeostasis in worms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115754     DOI: 10.1242/dev.01135

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  22 in total

1.  Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors.

Authors:  Sung Min Han; Hiroshi Tsuda; Youfeng Yang; Jack Vibbert; Pauline Cottee; Se-Jin Lee; Jessica Winek; Claire Haueter; Hugo J Bellen; Michael A Miller
Journal:  Dev Cell       Date:  2012-01-19       Impact factor: 12.270

2.  Distinct Caenorhabditis elegans HLH-8/twist-containing dimers function in the mesoderm.

Authors:  Mary C Philogene; Stephany G Meyers Small; Peng Wang; Ann K Corsi
Journal:  Dev Dyn       Date:  2012-01-31       Impact factor: 3.780

3.  Two types of chloride transporters are required for GABA(A) receptor-mediated inhibition in C. elegans.

Authors:  Andrew Bellemer; Taku Hirata; Michael F Romero; Michael R Koelle
Journal:  EMBO J       Date:  2011-03-22       Impact factor: 11.598

Review 4.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

5.  Multiple functions and dynamic activation of MPK-1 extracellular signal-regulated kinase signaling in Caenorhabditis elegans germline development.

Authors:  Min-Ho Lee; Mitsue Ohmachi; Swathi Arur; Sudhir Nayak; Ross Francis; Diane Church; Eric Lambie; Tim Schedl
Journal:  Genetics       Date:  2007-12       Impact factor: 4.562

Review 6.  Canonical RTK-Ras-ERK signaling and related alternative pathways.

Authors:  Meera V Sundaram
Journal:  WormBook       Date:  2013-07-11

7.  Identification and characterization of novel nicotinic receptor-associated proteins in Caenorhabditis elegans.

Authors:  Alexander Gottschalk; Ruta B Almedom; Thorsten Schedletzky; Scott D Anderson; John R Yates; William R Schafer
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

Review 8.  Invading, Leading and Navigating Cells in Caenorhabditis elegans: Insights into Cell Movement in Vivo.

Authors:  David R Sherwood; Julie Plastino
Journal:  Genetics       Date:  2018-01       Impact factor: 4.562

9.  Different isoforms of the C. elegans FGF receptor are required for attraction and repulsion of the migrating sex myoblasts.

Authors:  Te-Wen Lo; Catherine S Branda; Peng Huang; Isaac E Sasson; S Jay Goodman; Michael J Stern
Journal:  Dev Biol       Date:  2008-03-28       Impact factor: 3.582

10.  Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival.

Authors:  Patrick Narbonne; Richard Roy
Journal:  Nature       Date:  2008-12-03       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.